Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience

Oseltamivir (Tamiflu®; F. Hoffmann-La Roche Ltd, Basel, Switzerland) is an orally administered antiviral for the treatment and prevention of influenza A and B infections that is registered in more than 100 countries worldwide. More than 83 million patients have been exposed to the product since its...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, James R., Rayner, Craig R., Donner, Barbara, Wollenhaupt, Martina, Klumpp, Klaus, Dutkowski, Regina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare Communications 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101998/
https://www.ncbi.nlm.nih.gov/pubmed/22057727
http://dx.doi.org/10.1007/s12325-011-0072-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101998/
https://www.ncbi.nlm.nih.gov/pubmed/22057727
http://dx.doi.org/10.1007/s12325-011-0072-7

Ejemplares similares